Drug profile · INN
docetaxel
DOCETAXEL ACCORD
docetaxel (DOCETAXEL ACCORD) is a tubulin inhibitor. Associated with Accord Healthcare Pty.. Route of administration: injection. Current US regulatory status: approved.
Drug details — docetaxel
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- INJECTION
- Patents
- 20
- Programs
- 120
- Data quality
- 0.89
Quick answer
docetaxel (DOCETAXEL ACCORD) is a tubulin inhibitor. Associated with Accord Healthcare Pty.. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Tubulin inhibitor
Primary target: Tubulin
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
-
US 12258366
Bicyclic heteroaryl compounds and uses thereof
granted -
US 11987590
Compounds that participate in cooperative binding and uses thereof
granted -
US 11607407
Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use
granted -
US 11512128
VEGF/DLL4 binding agents and uses thereof
granted -
US 11434204
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted -
US 11234967
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
granted -
US 11168102
Bicyclic heteroaryl compounds and uses thereof
granted -
US 11059830
Compounds that participate in cooperative binding and uses thereof
granted -
US 10995071
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted -
US 10948495
Methods and reagents for analyzing protein-protein interfaces
granted -
US 10934260
Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted -
US 10624887
Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14,-diol
granted -
US 10533016
Compounds that participate in cooperative binding and uses thereof
granted -
US 10466249
Methods and reagents for analyzing protein-protein interfaces
granted -
US 10080720
Pharmaceutical composition containing docetaxel
granted -
US 9364430
Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol
granted -
US 2013178639
CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING THE SAME
granted -
US 8481511
Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process
granted -
US 8329744
Methods of preventing the serotonin syndrome and compositions for use thereof
granted -
US 8044093
Pharmaceutical compositions comprising docetaxel and methods for preparation thereof
granted
Frequently asked questions
What is docetaxel?
docetaxel (DOCETAXEL ACCORD) is a tubulin inhibitor. Associated with Accord Healthcare Pty.. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for docetaxel?
DOCETAXEL ACCORD is a marketed brand name for docetaxel. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of docetaxel?
docetaxel has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.